Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1999
08/24/1999CA2110510C Cold tolerances in plants
08/24/1999CA2082650C Method and apparatus for biopolymer synthesis
08/24/1999CA2082044C Modulation of gene expression through interference with rna secondary structure
08/24/1999CA1340716C Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides
08/24/1999CA1340715C Bovine interleukin-1b
08/20/1999CA2261183A1 Adenoviral transfer vector for the gene transport of a dna sequence
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041614A2 Method for detecting intimin producing microorganisms
08/19/1999WO1999041612A1 Methods and compositions for diagnosis of hepatoma
08/19/1999WO1999041610A1 Serological diagnosis of chagas' disease
08/19/1999WO1999041608A2 Interaction between cyclin d1 and steroid receptor co-activators
08/19/1999WO1999041415A1 Transposable element-anchored, amplification method for isolation and identification of tagged genes
08/19/1999WO1999041412A1 A novel npg-1 gene that is differentially expressed in prostate tumors
08/19/1999WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999WO1999041399A1 Methods for purified aav vector production
08/19/1999WO1999041398A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
08/19/1999WO1999041397A1 Anti-viral vectors
08/19/1999WO1999041393A1 Insecticidal peptides
08/19/1999WO1999041392A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
08/19/1999WO1999041391A1 Promoter inductible in plants, sequence incorporating same and resulting product
08/19/1999WO1999041390A2 Expression vector for the production of dead proteins
08/19/1999WO1999041389A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/19/1999WO1999041383A1 Antigen library immunization
08/19/1999WO1999041382A2 A novel interleukin-3 and uses thereof
08/19/1999WO1999041381A1 Neuroserpin
08/19/1999WO1999041379A2 Members of the d52 gene family
08/19/1999WO1999041378A1 Members of the d52 gene family
08/19/1999WO1999041377A1 Novel cystine knot protein and materials and methods for making it
08/19/1999WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999WO1999041375A2 Human receptor proteins
08/19/1999WO1999041374A2 Human short-chain tnf-receptor family protein
08/19/1999WO1999041373A2 Human transport-associated molecules
08/19/1999WO1999041372A1 Potassium channel polypeptide
08/19/1999WO1999041370A1 Cea/nca-based differentiation cancer therapy
08/19/1999WO1999041369A2 Genetic vaccine vector engineering
08/19/1999WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999WO1999041366A1 Introduction of nucleic acid into skin cells by topical application
08/19/1999WO1999041365A1 H2-o modified transgenic animals
08/19/1999WO1999041363A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999WO1999041355A2 Hiv chemokines
08/19/1999WO1999041284A1 Secreted proteins and polynucleotides encoding them
08/19/1999WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same
08/19/1999WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999WO1999041281A1 Modulation of hedgehog-mediated signaling pathway
08/19/1999WO1999041280A1 METHOD FOR PURIFYING PrPres FROM A BIOLOGICAL SAMPLE AND APPLICATIONS
08/19/1999WO1999041279A2 Methods and compositions comprising the use of blocked b-amyloid peptide
08/19/1999WO1999041274A1 A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions
08/19/1999WO1999041273A2 Pna and dna conjugates and methods for preparation thereof
08/19/1999WO1999041271A1 High affinity nucleic acid ligands of complement system proteins
08/19/1999WO1999041270A1 Compositions and methods for the inhibition of muc-5 mucin gene expression
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040940A1 Ligands of the cd47 antigen, agents binding the ligands of the cd47 antigen and uses thereof
08/19/1999WO1999040938A2 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999WO1999040935A1 Novel preventives/remedies for immunopathy
08/19/1999WO1999040934A1 Strategically modified hepatitis b core proteins and their derivatives
08/19/1999WO1999040928A1 Novel mixed amylin activity compounds
08/19/1999WO1999033985A3 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION
08/19/1999WO1999031269A3 New candida albicans kre9 and uses thereof
08/19/1999WO1999031250A3 Constitutive expression of non-infectious hiv-like particles
08/19/1999WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999WO1999029871A3 Circovirus sequences related to piglet weight loss disease (pwd)
08/19/1999WO1999025844A9 Mammalian cell death preventing kinase, dpk
08/19/1999WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents
08/19/1999WO1999024074A3 Novel conjugates of opioids and endogenous carriers
08/19/1999WO1999024058A3 Neuronal uses of bmp-11
08/19/1999WO1999023214A9 Compositions and methods for enhancing cardiac contractility mediated by myocyte p2 purinoceptors and models thereof
08/19/1999WO1999004266A3 Interactions of atm, atr or dna-pk with p53
08/19/1999WO1998050423A3 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis
08/19/1999WO1998030590A9 Analogs of parathyroid hormone
08/19/1999DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer
08/19/1999CA2632106A1 Method for modulating macrophage activation
08/19/1999CA2521289A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/19/1999CA2321160A1 Methods and compositions for diagnosis of hepatoma
08/19/1999CA2321105A1 Human short-chain tnf-receptor family protein
08/19/1999CA2321097A1 Anti-viral vectors
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320958A1 Antigen library immunization
08/19/1999CA2320806A1 Members of the d52 gene family
08/19/1999CA2320784A1 Members of the d52 gene family
08/19/1999CA2320753A1 Method for detecting intimin producing microorganisms
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320618A1 Secreted proteins and polynucleotides encoding them
08/19/1999CA2320517A1 Expression vector for the production of dead proteins
08/19/1999CA2320515A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999CA2320513A1 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
08/19/1999CA2320512A1 Novel preventives/remedies for immunopathy
08/19/1999CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999CA2320427A1 Human receptor proteins
08/19/1999CA2320424A1 Human transport-associated molecules
08/19/1999CA2320420A1 Promoter inductible in plants, sequence incorporating same and resulting product
08/19/1999CA2320401A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
08/19/1999CA2320391A1 Novel cystine knot protein and materials and methods for making it
08/19/1999CA2320383A1 Hiv chemokines
08/19/1999CA2320226A1 Methods and compositions for modulating leptin activity
08/19/1999CA2320041A1 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999CA2320031A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/19/1999CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999CA2319212A1 Methods for purified aav vector production
08/19/1999CA2319167A1 Interaction between cyclin d1 and steroid receptor co-activators
1 ... 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 ... 2916